アジア太平洋地域の免疫測定-ガンマカウンター市場、製品タイプ別（自動、手動/半自動）、ウェル別（マルチウェル、シングルウェル）、用途別（放射性免疫測定、核医学測定、その他）、病状別（がんバイオマーカー、感染症、治療薬モニタリング、内分泌ホルモン、アレルギー、新生児スクリーニング、心臓マーカー、自己免疫疾患、その他）、購入モード別（一括購入、レンタル購入）、エンドユーザー別（研究所、病院、研究・学術機関、製薬・バイオテクノロジー企業、血液銀行、その他）、流通チャネル別（直接入札、サードパーティ販売業者）、国別（日本、中国、オーストラリア、インド、韓国、シンガポール、インドネシア、タイ、マレーシア、フィリピン、ベトナム、その他のアジア太平洋地域）業界動向と2028年までの予測。
市場分析と洞察: アジア太平洋地域の免疫測定ガンマカウンター市場
アジア太平洋地域の免疫測定ガンマカウンター市場は、2021年から2028年の予測期間に市場が成長すると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に6.9％のCAGRで成長し、2028年までに2,345万米ドルに達すると分析しています。慢性疾患の有病率の増加と核医学の採用の増加は、予測期間における市場の需要を推進する主な原動力です。
免疫測定法は、抗体または抗原を使用して溶液中の高分子または小分子の存在または濃度を測定する生化学検査です。生化学検査は、「ガンマカウンター」と呼ばれる装置を使用して行われます。ガンマカウンターは、放射性核種から放出されるガンマ線を測定する機器です。サーベイメーターとは異なり、ガンマカウンターは放射性物質の小さなサンプルを測定するように設計されており、通常は複数のサンプルの自動測定と移動を行います。研究開発費の増加、医療費の増加、慢性疾患治療に対する患者の意識の高まりにより、市場には有利な成長機会がもたらされると予想されています。ただし、ガンマカウンターの高コストとガンマ線のリスクは、予測期間中の市場成長を抑制する要因になると予想されます。
免疫測定ガンマカウンター市場レポートでは、市場シェア、新開発、製品パイプライン分析、国内および現地の市場プレーヤーの影響の詳細、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点から見た機会の分析が提供されます。分析と市場シナリオを理解するには、アナリスト概要についてお問い合わせください。当社のチームが、希望する目標を達成するための収益影響ソリューションの作成をお手伝いします。
アジア太平洋地域の免疫測定ガンマカウンター市場の範囲と市場規模
免疫測定ガンマカウンター市場は、製品タイプ、井戸、用途、病状、購入モード、エンドユーザー、流通チャネルに基づいてセグメント化されています。セグメント間の成長は、ニッチな成長分野と市場にアプローチするための戦略を分析し、コアアプリケーション領域とターゲット市場の違いを決定するのに役立ちます。
- 製品タイプに基づいて、アジア太平洋地域の免疫アッセイ-ガンマカウンター市場は、自動、手動/半自動に分類されます。2021年には、ROIの高速化、生産量の増加、環境フットプリントの削減を実現するため、自動化セグメントが市場を支配すると予想されます。
- ウェルに基づいて、アジア太平洋地域の免疫測定ガンマカウンター市場は、マルチウェルとシングルウェルに分類されます。2021年には、正確な測定と、短期間でより高いスペクトルレベルを生成する能力により、マルチウェルセグメントが市場を支配すると予想されます。
- 用途に基づいて、アジア太平洋地域の免疫測定ガンマカウンター市場は、ラジオ免疫測定、核医学測定、その他に分類されます。2021年には、非常に特異的な免疫反応と免疫反応のより高い感度により、ラジオ免疫測定が市場を支配すると予想されます。
- アジア太平洋地域の免疫測定ガンマカウンター市場は、病状に基づいて、がんバイオマーカー、感染症、治療薬モニタリング、内分泌ホルモン、アレルギー、新生児スクリーニング、心臓マーカー、自己免疫疾患、その他に分類されています。2021年には、技術の進歩、政府および民間部門によるがん診断の研究開発への投資の増加により、がんバイオマーカーセグメントが市場を支配すると予想されています。
- 購入モードに基づいて、アジア太平洋の免疫アッセイガンマカウンター市場は、一括購入、レンタル購入に分類されます。2021年には、減価償却控除の可能性、価格または総コストの削減により、一括購入セグメントが市場を支配すると予想されます。
- エンドユーザーに基づいて、アジア太平洋地域の免疫測定ガンマカウンター市場は、研究室、病院、研究・学術機関、製薬・バイオテクノロジー企業、血液銀行、その他に分類されます。2021年には、正確さと精度により、研究室セグメントが市場を支配すると予想されます。
- 流通チャネルに基づいて、アジア太平洋地域の免疫アッセイ-ガンマカウンター市場は、直接販売とサードパーティの販売代理店に分割されています。2021年には、効率性が向上し、充填までの時間が短縮されるため、直接入札セグメントが市場を支配すると予想されます。
免疫測定ガンマカウンター市場の国別分析
免疫測定ガンマカウンター市場は分析され、上記の製品タイプ、ウェル、アプリケーション、病状、購入モード、エンドユーザー、流通チャネルに基づいて市場規模の情報が提供されます。
下剤市場レポートで取り上げられている国は、日本、中国、インド、オーストラリア、韓国、シンガポール、マレーシア、タイ、インドネシア、フィリピン、ベトナム、およびその他のアジア太平洋諸国です。
日本の一括購入セグメントは、減価償却控除や税制優遇措置の可能性により、2021年から2028年の予測期間に最も高い成長率で成長すると予想されています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、アジア太平洋ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面する課題、販売チャネルの影響も考慮されます。
製品承認と診断手順の新規性により、免疫測定ガンマカウンターの市場成長が促進されている。
免疫測定ガンマカウンター市場では、医薬品販売、進歩の影響、技術、免疫測定ガンマカウンターのサポートに関する規制シナリオの変化など、免疫測定ガンマカウンター業界の各国での成長に関する詳細な市場分析も提供しています。データは、2011年から2019年までの履歴期間について入手できます。
競争環境と免疫測定ガンマカウンター市場 シェア分析
免疫測定ガンマカウンター市場の競争状況は、競合他社ごとに詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と広さ、アプリケーションの優位性、技術ライフライン曲線が含まれます。提供されている上記のデータポイントは、免疫測定ガンマカウンター市場に関連する会社の焦点にのみ関連しています。
アジア太平洋地域の免疫測定ガンマカウンター市場で事業を展開している主要企業としては、Hidex Oy、Perkin Elmer Inc、Berthold Technologies GmbH & Co. KG、ENERSYS Co. Ltd、Shinjin Medics Inc、LabLogic Systems Ltd などがあります。
世界中の企業によって多くの製品の発売や契約も開始されており、免疫測定ガンマカウンター市場も加速しています。
例えば、
- 2021年7月、パーキンエルマー社は、革新的な製品を活用してインドでの事業展開をさらに拡大することを目指していると発表しました。新製品は、科学、製薬、食品検査など、さまざまな分野で発売されます。これにより、同社は世界的なプレゼンスを拡大しています。
- 2020年11月、Berthold Technologies GmbH & C0.KGは、感染率を下げるために部分的なロックダウンを命じたと発表しました。しかし、同社は政府の適切なガイドラインに従ってこの期間中も生産を継続し、確実な納品を顧客に保証しました。これにより、同社はパンデミック中に需要を維持し、収益を生み出すことができます。
市場プレーヤーによるコラボレーション、製品の発売、事業拡大、賞や表彰、合弁事業、その他の戦略により、免疫測定ガンマカウンター市場における企業市場が強化され、組織が免疫測定ガンマカウンターの提供を改善するメリットももたらされます。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTES FIVE FORCES
5 REGULATORY GUIDELINES FOR IMMUNOASSAY-GAMMA COUNTERS
5.1 U.S. REGULATORY GUIDELINES FOR IMMUNOASSAYS-GAMMA COUNTERS
5.2 EUROPE REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS
5.3 JAPAN REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS
5.4 CHINA REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASE IN PREVALENCE OF CHRONIC DISEASES
6.1.2 PRODUCT APPROVAL
6.1.3 INCREASE IN ADOPTION OF NUCLEAR MEDICINE
6.1.4 NOVELTY IN DIAGNOSIS PROCEDURES
6.1.5 UPGRADING GAMMA TECHNOLOGY
6.2 RESTRAINTS
6.2.1 HIGH COST OF GAMMA COUNTER
6.2.2 RISK OF GAMMA RADIATION
6.2.3 STRINGENT REGULATION OF CLINICAL USE OF GAMMA COUNTER
6.2.4 PRODUCT RECALL
6.3 OPPORTUNITIES
6.3.1 GROWING RESEARCH AND DEVELOPMENT EXPENDITURE
6.3.2 INCREASE IN HEALTHCARE EXPENDITURE
6.3.3 RISE IN PATIENTS AWARENESS TOWARDS CHRONIC DISEASE TREATMENT
6.4 CHALLENGES
6.4.1 CHALLENGES IN USING GAMMA COUNTER
6.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
7 IMPACT OF COVID-19 ON ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET
7.1 IMPACT ON THE PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY
7.4 STRATEGIC INITIATIVES BY MANUFACTURERS
7.5 CONCLUSION
8 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 AUTOMATED
8.2.1 RADIOIMMUNOASSAYS
8.2.1.1 RIA
8.2.1.2 IRMA
8.2.2 NUCLEAR MEDICINE ASSAYS
8.2.2.1 GFR (Glomerular FILTRATION RATE)
8.2.2.2 Gamma glutamyl transferase (ggt)
8.2.2.3 red cell mass and plasma volume test
8.2.2.4 THE SCHILLING TEST
8.2.2.5 others
8.2.3 OTHERS
8.3 MANUAL/SEMI-AUTOMATED
8.3.1 RADIOIMMUNOASSAYS
8.3.1.1 RIA
8.3.1.2 IRMA
8.3.2 NUCLEAR MEDICINE ASSAYS
8.3.2.1 GFR (Glomerular FILTRATION RATE)
8.3.2.2 Gamma glutamyl transferase (ggt)
8.3.2.3 red cell mass and plasma volume test
8.3.2.4 THE SCHILLING TEST
8.3.2.5 others
8.3.3 OTHERS
9 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL
9.1 OVERVIEW
9.2 MULTI-WELL
9.3 SINGLE-WELL
10 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 RADIO IMMUNOASSAYS
10.2.1 RIA
10.2.2 IRMA
10.3 NUCLEAR MEDICINE ASSAY
10.3.1 GFR (GLOMERULAR FILTRATION RATE)
10.3.2 GAMMA-GLUTAMYL TRANSFERASE
10.3.3 RED CELL MASS AND PLASMA VOLUME TEST
10.3.4 THE SCHILLING TEST
10.3.5 OTHERS
10.4 OTHERS
11 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION
11.1 OVERVIEW
11.2 CANCER BIOMARKERS
11.2.1 CARBOHYDRATE ANTIGEN 125 (CA125)
11.2.2 CARBOHYDRATE ANTIGEN 19-9
11.2.3 CARCINO EMBRYONIC ANTIGEN
11.2.4 ALPHA-FETOPROTEIN
11.2.5 OTHERS
11.3 INFECTIOUS DISEASES
11.4 THERAPEUTIC DRUG MONITORING
11.5 ENDOCRINE HORMONES
11.6 ALLERGY
11.7 NEONATAL SCREENING
11.8 CARDIAC MARKERS
11.9 AUTOIMMUNE DISEASE
11.1 OTHERS
12 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE
12.1 OVERVIEW
12.2 OUTRIGHT PURCHASE
12.3 RENTAL PURCHASE
13 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 THIRD PARTY DISTRIBUTORS
14 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER
14.1 OVERVIEW
14.2 HOSPITALS
14.3 LABORATORY
14.4 BLOOD BANKS
14.5 RESEARCH AND ACADEMIC INSTITUTES
14.6 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
14.7 OTHERS
15 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY GEOGRAPHY
15.1 ASIA-PACIFIC
15.1.1 JAPAN
15.1.2 SOUTH KOREA
15.1.3 CHINA
15.1.4 AUSTRALIA
15.1.5 INDIA
15.1.6 SINGAPORE
15.1.7 THAILAND
15.1.8 MALAYSIA
15.1.9 INDONESIA
15.1.10 PHILIPPINES
15.1.11 REST OF ASIA-PACIFIC
16 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 PERKINELMER INC.
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 BRETHOLD TECHNOLOGIES GMBH & CO.KG
18.2.1 COMPANY SNAPSHOT
18.2.2 COMPANY SHARE ANALYSIS
18.2.3 PRODUCT PORTFOLIO
18.2.4 RECENT DEVELOPMENTS
18.3 LABLOGIC SYSTEMS LTD.
18.3.1 COMPANY SNAPSHOT
18.3.2 COMPANY SHARE ANALYSIS
18.3.3 PRODUCT PORTFOLIO
18.3.4 RECENT DEVELOPMENT
18.4 SHIN JIN MEDICS INC.
18.4.1 COMPANY SNAPSHOT
18.4.2 COMPANY SHARE ANALYSIS
18.4.3 PRODUCT PORTFOLIO
18.4.4 RECENT DEVELOPMENTS
18.5 HIDEX OY
18.5.1 COMPANY SNAPSHOT
18.5.2 COMPANY SHARE ANALYSIS
18.5.3 PRODUCT PORTFOLIO
18.5.4 RECENT DEVELOPMENTS
18.6 LABORATORY TECHNOLOGIES. INC.
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENT
18.7 ENERSYS, CO.LTD.
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENTS
18.8 MIRION TECHNOLOGIES (CAPINTEC),INC.
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
表のリスト
TABLE 1 NUMBER OF PEOPLE WITH DIABETES (MILLION) AMONG AGES 20–79 YEARS
TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
TABLE 3 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC MULTI-WELL IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC SINGLE-WELL IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC RADIO IMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC RADIO IMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC NUCLEAR MEDICINE ASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC OTHERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC INFECTIOUS DISEASES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC THERAPEUTIC DRUG MONITORING IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC ENDOCRINE HORMONES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC ALLERGY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC NEONATAL SCREENING IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC CARDIAC MAKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC AUTO IMMUNE DISEASE IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC OTHERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC OUTRIGHT PURCHASE IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC RENTAL PURCHASE IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC DIRECT TENDER IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC THIRD PARTY DISTRIBUTORS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC HOSPITALS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC LABORATORY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 41 ASIA-PACIFIC BLOOD BANKS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 20152028 (USD MILLION)
TABLE 42 ASIA-PACIFIC RESEARCH AND ACADEMIC INSTITUTES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 44 OTHERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 45 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY COUNTRY, 2015-2028 (USD MILLION)
TABLE 46 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 47 ASIA-PACIFIC AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 48 ASIA-PACIFIC RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 49 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 50 ASIA-PACIFIC MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 51 ASIA-PACIFIC RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 52 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 53 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 54 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 55 ASIA-PACIFIC RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 56 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 57 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 58 ASIA-PACIFIC CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 59 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 60 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 61 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 62 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 63 JAPAN AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 64 JAPAN RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 65 JAPAN NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 66 JAPAN MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 67 JAPAN RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 68 JAPAN NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 69 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 70 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 71 JAPAN RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 72 JAPAN NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 73 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 74 JAPAN CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 75 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 76 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 77 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 78 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 79 SOUTH KOREA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 80 SOUTH KOREA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 81 SOUTH KOREA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 82 SOUTH KOREA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 83 SOUTH KOREA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 84 SOUTH KOREA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 85 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 86 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 87 SOUTH KOREA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 88 SOUTH KOREA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 89 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 90 SOUTH KOREA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 91 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 92 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 93 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 94 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 95 CHINA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 96 CHINA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 97 CHINA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 98 CHINA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 99 CHINA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 100 CHINA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 101 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 102 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 103 CHINA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 104 CHINA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 105 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 106 CHINA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 107 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 108 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 109 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 110 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 111 AUSTRALIA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 112 AUSTRALIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 113 AUSTRALIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 114 AUSTRALIA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 115 AUSTRALIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 116 AUSTRALIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 117 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 118 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 119 AUSTRALIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 120 AUSTRALIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 121 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 122 AUSTRALIA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 123 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 124 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 125 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 126 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 127 INDIA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 128 INDIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 129 INDIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 130 INDIA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 131 INDIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 132 INDIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 133 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 134 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 135 INDIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 136 INDIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 137 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 138 INDIA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 139 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 140 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 141 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 142 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 143 SINGAPORE AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 144 SINGAPORE RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 145 SINGAPORE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 146 SINGAPORE MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 147 SINGAPORE RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 148 SINGAPORE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 149 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 150 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 151 SINGAPORE RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 152 SINGAPORE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 153 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 154 SINGAPORE CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 155 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 156 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 157 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 158 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 159 THAILAND AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 160 THAILAND RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 161 THAILAND NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 162 THAILAND MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 163 THAILAND RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 164 THAILAND NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 165 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 166 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 167 THAILAND RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 168 THAILAND NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 169 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 170 THAILAND CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 171 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 172 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 173 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 174 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 175 MALAYSIA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 176 MALAYSIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 177 MALAYSIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 178 MALAYSIA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 179 MALAYSIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 180 MALAYSIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 181 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 182 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 183 MALAYSIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 184 MALAYSIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 185 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 186 MALAYSIA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 187 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 188 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 189 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 190 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 191 INDONESIA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 192 INDONESIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 193 INDONESIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 194 INDONESIA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 195 INDONESIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 196 INDONESIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 197 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 198 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 199 INDONESIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 200 INDONESIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 201 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 202 INDONESIA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 203 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 204 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 205 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 206 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 207 PHILIPPINES AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 208 PHILIPPINES RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 209 PHILIPPINES NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 210 PHILIPPINES MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 211 PHILIPPINES RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 212 PHILIPPINES NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 213 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 214 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 215 PHILIPPINES RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 216 PHILIPPINES NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 217 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 218 PHILIPPINES CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 219 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 220 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 221 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 222 REST OF ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
図表一覧
FIGURE 1 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: APPLICATION COVERAGE GRID
FIGURE 10 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: SEGMENTATION
FIGURE 12 INCREASE IN PREVALENCE OF CHRONIC DISEASES AND GROWING USE OF NUCLEAR MEDICINE IS EXPECTED TO DRIVE THE ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 AUTOMATED IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET
FIGURE 15 HEALTH SPENDING BY MAJOR SOURCES OF FUNDS
FIGURE 16 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, 2020
FIGURE 17 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, 2021-2028 (USD MILLION)
FIGURE 18 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 19 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 20 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, 2020
FIGURE 21 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, 2021-2028 (USD MILLION)
FIGURE 22 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, CAGR (2021-2028)
FIGURE 23 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, LIFELINE CURVE
FIGURE 24 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, 2020
FIGURE 25 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 26 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, CAGR (2021-2028)
FIGURE 27 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, LIFELINE CURVE
FIGURE 28 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISEASE CONDITION, 2020
FIGURE 29 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: BY DISEASE CONDITION, 2021-2028 (USD MILLION)
FIGURE 30 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISEASE CONDITION, CAGR (2021-2028)
FIGURE 31 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISEASE CONDITION, LIFELINE CURVE
FIGURE 32 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, 2020
FIGURE 33 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, 2021-2028 (USD MILLION)
FIGURE 34 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, CAGR (2021-2028)
FIGURE 35 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, LIFELINE CURVE
FIGURE 36 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, 2020
FIGURE 37 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 38 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 39 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, 2020
FIGURE 41 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, 2021-2028 (USD MILLION)
FIGURE 42 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, CAGR (2021-2028)
FIGURE 43 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, LIFELINE CURVE
FIGURE 44 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: SNAPSHOT (2020)
FIGURE 45 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: BY COUNTRY (2020)
FIGURE 46 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: BY COUNTRY (2021 &2028)
FIGURE 47 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 48 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: BY PRODUCT TYPE (2021-2028)
FIGURE 49 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: COMPANY SHARE 2020 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
